Related Experiment Video

Updated: Dec 5, 2025

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
08:04

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method

Published on: October 23, 2018

19.5K

AMP-independent activator of AMPK for treatment of mitochondrial disorders

Tereza Moore1, Rolando E Yanes2, Melissa A Calton3

  • 1Department of Pathology, Stanford University, Palo Alto, CA, United States of America.

Plos One
|October 14, 2020
PubMed

Insights

Researchers identified direct AMP-activated protein kinase (AMPK) activators as potential treatments for mitochondrial diseases. These compounds improved mitochondrial function and protected against retinal degeneration in preclinical models.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Mitochondrial diseases result from respiratory chain dysfunction, leading to progressive, multi-systemic conditions.
  • Currently, no effective treatments or FDA-approved drugs exist for mitochondrial diseases.
  • Existing AMPK activators have limitations, including AMP-dependency and potential pleiotropic effects.

Purpose of the Study:

  • To identify novel therapeutic compounds for mitochondrial diseases.
  • To characterize direct AMP-activated protein kinase (AMPK) activators with improved specificity.
  • To evaluate the therapeutic potential of AMP-independent AMPK agonists.

Main Methods:

  • Development of an in vitro screening assay for therapeutic compounds.
  • Identification and characterization of direct AMPK activators.
  • Assessment of compound effects on cellular respiration, energy status, and redox balance.
  • Evaluation of a lead compound (PT1) in a mouse model of photoreceptor degeneration.

Main Results:

  • A novel class of direct, AMP-independent AMPK activators was identified.
  • The compound PT1 demonstrated significant improvements in mitochondrial function.
  • PT1 treatment protected against retinal degeneration in a mouse model.
  • AMP-independent AMPK activation offers increased specificity and reduced pleiotropic effects.

Conclusions:

  • Direct, AMP-independent AMPK activators represent a promising therapeutic strategy for mitochondrial diseases.
  • PT1 shows potential for treating conditions involving mitochondrial dysfunction and oxidative stress.
  • Further investigation into this class of compounds may lead to effective treatments for currently intractable diseases.

More Related Videos

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice08:01

Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice

Published on: May 16, 2021

6.3K
The Use of the Patch-Clamp Technique to Study the Thermogenic Capacity of Mitochondria11:05

The Use of the Patch-Clamp Technique to Study the Thermogenic Capacity of Mitochondria

Published on: May 3, 2021

4.2K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.6K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
10.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
17.5K